The Mets won, which is good. But they lost two key players in doing so. One for a short time, one assumes, the other for longer.
Juan Lagares left last night’s game with a pulled right hamstring after reaching on a fielder’s choice in the seventh inning. Lagares, one assumes, will head to the disabled list. A big blow, this, as Lagares has been hitting well and his defense is fantastic.
Less serious was Curtis Granderson’s mishap. He crashed into the right field while during the first inning, and eventually left the game. His x-rays came back negative, but he still may miss some time.
All of which will make things tough this week as the Mets don’t get Chris Young back from the DL until Friday. So is a Bobby Abreu callup in their future? God, I hope so.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.